401 Stock Overview
An investment holding company, engages in pharmaceutical wholesale and distribution business in the Mainland China and Hong Kong. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Wanjia Group Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.073 |
| 52 Week High | HK$0.099 |
| 52 Week Low | HK$0.042 |
| Beta | 0.20 |
| 11 Month Change | 17.74% |
| 3 Month Change | 55.32% |
| 1 Year Change | -26.26% |
| 33 Year Change | -54.37% |
| 5 Year Change | -74.83% |
| Change since IPO | -98.20% |
Recent News & Updates
Wanjia Group Holdings Limited's (HKG:401) Shares Leap 63% Yet They're Still Not Telling The Full Story
Sep 30
It Looks Like Wanjia Group Holdings Limited's (HKG:401) CEO May Expect Their Salary To Be Put Under The Microscope
Sep 06Investors Give Wanjia Group Holdings Limited (HKG:401) Shares A 31% Hiding
Jul 30Recent updates
Wanjia Group Holdings Limited's (HKG:401) Shares Leap 63% Yet They're Still Not Telling The Full Story
Sep 30It Looks Like Wanjia Group Holdings Limited's (HKG:401) CEO May Expect Their Salary To Be Put Under The Microscope
Sep 06Investors Give Wanjia Group Holdings Limited (HKG:401) Shares A 31% Hiding
Jul 30Investors Continue Waiting On Sidelines For Wanjia Group Holdings Limited (HKG:401)
May 22Slammed 36% Wanjia Group Holdings Limited (HKG:401) Screens Well Here But There Might Be A Catch
Feb 02Wanjia Group Holdings (HKG:401) Will Be Looking To Turn Around Its Returns
Oct 05Wanjia Group Holdings Limited's (HKG:401) Popularity With Investors Under Threat As Stock Sinks 34%
Aug 02Wanjia Group Holdings (HKG:401) Might Have The Makings Of A Multi-Bagger
Jun 24Wanjia Group Holdings (HKG:401) Is Looking To Continue Growing Its Returns On Capital
Mar 09There's Been No Shortage Of Growth Recently For Wanjia Group Holdings' (HKG:401) Returns On Capital
Nov 23Shareholder Returns
| 401 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 0% | -0.2% | 1.6% |
| 1Y | -26.3% | -25.8% | 10.1% |
Return vs Industry: 401 underperformed the Hong Kong Healthcare industry which returned -23.3% over the past year.
Return vs Market: 401 underperformed the Hong Kong Market which returned 12% over the past year.
Price Volatility
| 401 volatility | |
|---|---|
| 401 Average Weekly Movement | 19.5% |
| Healthcare Industry Average Movement | 7.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 19.0% |
| 10% least volatile stocks in HK Market | 4.3% |
Stable Share Price: 401's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 401's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 193 | Jia Jun Wang | www.wanjia-gp.com |
Wanjia Group Holdings Limited, an investment holding company, engages in pharmaceutical wholesale and distribution business in the Mainland China and Hong Kong. It also offers hemodialysis treatment and consultancy services. The company sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics.
Wanjia Group Holdings Limited Fundamentals Summary
| 401 fundamental statistics | |
|---|---|
| Market cap | HK$40.90m |
| Earnings (TTM) | -HK$39.98m |
| Revenue (TTM) | HK$181.09m |
0.2x
P/S Ratio-1.0x
P/E RatioIs 401 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 401 income statement (TTM) | |
|---|---|
| Revenue | HK$181.09m |
| Cost of Revenue | HK$126.35m |
| Gross Profit | HK$54.74m |
| Other Expenses | HK$94.72m |
| Earnings | -HK$39.98m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Nov 25, 2024
| Earnings per share (EPS) | -0.071 |
| Gross Margin | 30.23% |
| Net Profit Margin | -22.08% |
| Debt/Equity Ratio | 2.2% |
How did 401 perform over the long term?
See historical performance and comparison